Interní Med. 2013; 15(3-4): 125-129

Toxoallergic puzzle - clinical symptoms of metal toxicity and allergy. Case report

MUDr.Jan Maňoušek1, RNDr.Jiřina Bártová, CSc.2, RNDr.Štěpán Podzimek, Ph.D.2, doc.MUDr.Jarmila Procházková, CSc.2
Interní kardiologická klinika FN Brno1;
2 Ústav klinické a experimentální stomatologie Praha

Environmental factors are one of the causes of increased incidence of allergic, autoimmune, degenerative and demyelinating diseases.

These also include highly reactive metal ions being slowly released from dental fillings and other implants or those contained in products

of daily needs. In susceptible individuals they activate T-lymphocytes and trigger a chronic systemic inflammatory response. Production of

cytokines and increased oxidative stress lead to changes in tissues and organs. Clinically it may present with non-specific range of gradually

progressive, very stubborn and “unexplained” symptoms which are difficult to investigate but significantly impair quality of life. In addition to

routine toxicological testing the diagnostics is based mainly on the Melisa test. This proves the reactivity of memory cells of the immune

system to the appropriate metal. Removal of incompatible materials leads to long-term health improvement in most of the patients (1).

Keywords: amalgam, metal toxicity, immunopathological reactions, Melisa test, cytokines, oxydative stress, chronic fatigue syndrom (CFS)

Published: March 20, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Maňoušek J, Bártová J, Podzimek Š, Procházková J. Toxoallergic puzzle - clinical symptoms of metal toxicity and allergy. Case report. Interní Med. 2013;15(3-4):125-129.
Download citation

References

  1. Stejskal VDM, et al. Toxic metals as a key factor in disease, Neuroendocrinology Letters 2006; 27(Suppl 1).
  2. Stejskal J, Stejskal VDM. The role of metals in autoimmunity and the link to Neuroendocrinology. Neuroendocrinology Letters 1999; 20: 351-364. Go to original source... Go to PubMed...
  3. Mutter J. Is dental amalgam safe for humans? The opinion of the scientific committee of the European Commission. J Occup Med Toxicol. 2011; 6: 2. Go to original source... Go to PubMed...
  4. Guzzi G, Grandi M, Cattaneo C, Calza S, Minoia C, Ronchi A, Gatti A, Severi G. Dental amalgam and mercury levels in autopsy tissues: food for thought. Am J Forensic Med Pathol. 2006; 27: 42-45. Go to original source... Go to PubMed...
  5. Leong CCW, Syed NI, Lorscheider FL. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuro Report. 2001; 12: 733-737. Go to original source... Go to PubMed...
  6. Stenman S, Grans L. Symptoms and differential diagnosis of patients fearing mercury toxicity from amalgam fillings. Scand J Work Environ Health. 1997; 23: 59-63.
  7. Opitz H, Schweinsberg F, Grossmann T, Wendt-Gallitelli MF, Meyermann R. Demonstration of mercury in the human brain and other organs 17 years after metallic mercury exposure. Clin Neuropath. 1996; 15: 139-144.
  8. Akiyama M, Oshima H, Nakamura M. Genotoxicity of mercury used in chromosome aberration tests. Toxicol in Vitro. 2001; 15: 463-467. Go to original source... Go to PubMed...
  9. Di Pietro A, Visalli G, La Maestra S. Biomonitoring of DNA damage in peripheral blood lymphocytes of subjects with dental restorative fillings. Mutat Res. 2008; 650: 115-122. Go to original source... Go to PubMed...
  10. Bartova J, Prochazkova J, Kratka Z, Benetkova K, Venclikova Z, Sterzl I. Dental amalgam as one of the risk factors in autoimmune diseases. Neuro Endocrinol Lett. 2003; 24: 65-67. Go to PubMed...
  11. Mutter J, Naumann J, Sadaghiani C, Walach H. Quecksilber und die Alzheimer-Erkrankung. Fortschr Neuro Psychiat. 2007; 75: 528-538. Go to original source... Go to PubMed...
  12. Seidler A, Hellenbrand W, Robra BP. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology. 1996; 46: 1275-84. Go to original source... Go to PubMed...
  13. Ask K, Akesson A, Berglund M, Vahter M. Inorganic mercury and methylmercury in placentas of Swedish women. Environ Health Perspect. 2002; 110: 523-526. Go to original source... Go to PubMed...
  14. Hořejší V, Bartůňková J. Základy imunologie, 3. vydání. Praha: Triton, 2008: 280 s.
  15. Stejskal VDM, Cederbrant K, Lindvall A, Forsbeck M. MELISA - an in vitro tool for the study of metal allergy. Toxicol in Vitro 8(5): 991-1000. Go to original source... Go to PubMed...
  16. Stejskal VDM, Forsbeck M, Cederbrant KE, Asteman O. Mercury-specific lymphocytes: an indication of mercury allergy in man. J Clin Immunol. 16(1): 31-40.
  17. Cederbrant K, Hultman P, Marcusson JA, Tibbling L. In vitro lymphocyte proliferation as compared to patch test using gold, palladium and nickel. Int Arch Allergy Immunol. 112(3): 212-217.
  18. Hallab NJ, Caicedo M, Finnegan A, Jacobs JJ. Th1 type lymphocyte reactivity to metals in patients with total hip arthroplasty. Journal of Orthopaedic Surgery and Research 2008, 3: 6. Go to original source... Go to PubMed...
  19. Schwenk M, Klein R, Templeton DM. Immunological effects of mercury (IUPAC technical report). Pure Appl. Chem. 2009; 81(1): 153-167. Go to original source...
  20. Yaqob A. Danersund A. Stejskal VD. Lindvall A. Hudecek R. Lindh U. Metal-specific lymphocyte reactivity is downregulated after dental metal replacement. Neuroendocrinology Letters. 2006; 27(1-2): 189-197. Go to PubMed...
  21. Lindh U, Hudecek R, Danersund A, Eriksson S, Lindvall A. Removal of dental amalgam and other metal alloys supported by antioxidant therapy alleviates symptoms and improves quality of life in patients with amalgam-associated ill health. Neuro Endocrinol Lett. 2002; 23(5-6): 459-482. Go to PubMed...
  22. Prochazkova J, Sterzl I, Kucerova H, Bartova J, Stejskal V. The beneficial effect of amalgam replacement on health in patients with autoimunity. Neuroendocrinology Letters 2004; 25(3): 211-218. Go to PubMed...
  23. Nogueira CW, Soares FA, Nascimento PC, Muller D, Rocha JB. 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase. Toxicology. 2003; 184: 85-95. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.